126 related articles for article (PubMed ID: 6525083)
1. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
Gulati K; Mapa MK; Gupta AN; Singh PM; Devi PK
Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):281-6. PubMed ID: 6525083
[TBL] [Abstract][Full Text] [Related]
2. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
3. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
4. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
6. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
7. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
[TBL] [Abstract][Full Text] [Related]
8. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
McEwan JA; Griffin M
Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
[TBL] [Abstract][Full Text] [Related]
10. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
11. Contraception with progestagens in systemic lupus erythematosus.
Mintz G; Gutiérrez G; Delezé M; Rodríguez E
Contraception; 1984 Jul; 30(1):29-38. PubMed ID: 6434228
[TBL] [Abstract][Full Text] [Related]
12. A clinical and metabolic study of norethisterone oenanthate in Thai women.
Virutamasen P; Nitichai Y; Tangkeow P; Kankeerati W; Rienprayura D; Boonsiri B
Contraception; 1980 Oct; 22(4):397-408. PubMed ID: 7449388
[TBL] [Abstract][Full Text] [Related]
13. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
[TBL] [Abstract][Full Text] [Related]
14. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
Howard G; Myatt L; Elder MG
Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
[TBL] [Abstract][Full Text] [Related]
15. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
[TBL] [Abstract][Full Text] [Related]
16. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
18. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
19. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.
Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
Contraception; 1978 Jul; 18(1):1-6. PubMed ID: 679682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
